Around the world, the scientific community is devoting substantial effort and funding to dementia research. Researchers are looking for ways to prevent the disease, to improve quality of life for people living with the disease and to ultimately finding a cure to eradicate the disease.
The Alzheimer Society Research Program
The Alzheimer Society Research Program (ASRP) is one of Canada’s most innovative hubs for dementia research, helping the best and brightest minds in the field spark their work from ideas to impact.
Click here to find out more and apply today!
2022 Alzheimer Society Research Program Funding Competition
*This competition is now closed. Please stay tuned for updates in 2023!*
Researchers with big, bold, challenging new ideas relevant to Alzheimer’s disease and other dementias are encouraged to apply for the Alzheimer Society’s Proof of Concept Grant.
The Proof of Concept Grant provides $100,000 over up to 3 years to support investigators with innovative, high-risk, high-yield hypotheses about dementia.
The Alzheimer Society Research Program will pre-screen applications for the Proof of Concept Grant through a Letter of Intent (LOI) process. Successful LOI applicants will then be asked to submit a full application for peer review later in the summer.
Researchers with big, bold, challenging new ideas relevant to Alzheimer’s disease and other dementias are encouraged to apply.
The LOI form is available now with submissions due by July 11, 2022.
Please share this funding opportunity with anyone who may be interested in applying.
For more information, please contact firstname.lastname@example.org
Alzheimer Society Research Program
The 2022 Alzheimer Society Research Program (ASRP) is pleased to announce it has awarded $3.5 million to 31 researchers across the country to advance research related to all forms of dementia and find more effective means to diagnose, treat and eventually stop the disease, as well as improve day-to-day life and care.
The Manitoban researcher receiving funding this year is:
Francis Delicata, University of Manitoba
Title: Targeting Alzheimer’s Disease progression with reduced astrocyte P2Y1 receptor expression
Award/Grant: Postdoctoral award
“Alzheimer’s disease affects the brain. Different cells located in the brain become abnormal in patients suffering from this disease. This leads to harmful brain activity. As a result, patients suffer from memory and sensory problems. Other symptoms include reduced blood flow and sometimes, epileptic seizures.”
“New treatments are needed to help Canadians with Alzheimer’s disease. Our results will show that astrocytes may be used as a treatment target. This will lead to studies aimed at the development of new drugs to use in clinical trials to slow down or halt disease progression.”
Spotlight on Dementia Research
Dr. Saskia Sivananthan, a neuroscientist, global policy leader and Chief Science Officer at the Alzheimer Society of Canada, spoke to Manitobans at a recent seminar about the significant strides that researchers are taking to look for ways to prevent dementia, to improve the quality of life of those impacted and to ultimately find a cure. Her presentation from this seminar is available below.
Click here to view or download the presentation.
Graduate Student Fellowship Awards in Manitoba
Click here to find out how to apply researchers in Manitoba.
Participate in Research
Click here to find out how you can participate.
Click here for National studies looking for Canadians looking to participate.
Financial gifts directed towards research are crucial to help find better treatments and ultimately a cure for Alzheimer’s disease and other forms of dementia. Without proper funding, research breakthroughs go undiscovered.
Click here to make a donation today!